Fundraising Fox
🦊/Companies
Sign in

Enedra Therapeutics

3 known investors

Find your way into Enedra Therapeutics

Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data. The company uses its CASPAROV platform to identify conserved genetic patterns across tumor populations and cancer models.

AI & Machine LearningBiotechMedical Devices

Investors · 3

Deep Science VenturesLondon
KU Leuven Research & Development
O2h VenturesCambridge

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Enedra Therapeutics targets £8.5m seed fund raise for CASPAROVcambridgeindependent.co.uk · Dec 2025Enedra secures funding to advance AI-driven cancer platform - Drug Target Reviewdrugtargetreview.com · May 2025Enedra Therapeutics secures financing to advance drug discovery programmes from its proprietary CASPAROV platform for difficult to treat cancers - Oncology Todayoncologynewstoday.co.uk · May 2025Enedra secures financing for precision cancer therapies - Drug Discovery World (DDW)ddw-online.com · May 2025Enedra Therapeutics | Targeting Cancer's Ability to Evolve and Develop Treatment Resistanceo2hventures.com · May 2025

Frequently asked questions

What does Enedra Therapeutics do?
Enedra analyzes tumor evolution patterns by decoding convergent genomic signatures from cancer genomic data. The company uses its CASPAROV platform to identify conserved genetic patterns across tumor populations and cancer models.
Who are Enedra Therapeutics's investors?
Enedra Therapeutics's investors include Deep Science Ventures, KU Leuven Research & Development, O2h Ventures.